PharmaEssentia Corporation (TPE:6446)

PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of TWD 165.47 billion. The enterprise value is 145.63 billion.

Market Cap	165.47B
Enterprise Value	145.63B

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	Aug 11, 2025

Share Statistics

PharmaEssentia has 333.27 million shares outstanding. The number of shares has increased by 0.68% in one year.

Current Share Class	333.27M
Shares Outstanding	333.27M
Shares Change (YoY)	+0.68%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	8.74%
Owned by Institutions (%)	8.19%
Float	262.27M

Valuation Ratios

The trailing PE ratio is 40.97 and the forward PE ratio is 21.20.

PE Ratio	40.97
Forward PE	21.20
PS Ratio	13.10
PB Ratio	5.80
P/TBV Ratio	5.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 38.12, with an EV/FCF ratio of 74.54.

EV / Earnings	35.95
EV / Sales	11.53
EV / EBITDA	38.12
EV / EBIT	41.89
EV / FCF	74.54

Financial Position

The company has a current ratio of 7.71, with a Debt / Equity ratio of 0.03.

Current Ratio	7.71
Quick Ratio	7.24
Debt / Equity	0.03
Debt / EBITDA	0.25
Debt / FCF	0.48
Interest Coverage	138.58

Financial Efficiency

Return on equity (ROE) is 15.04% and return on invested capital (ROIC) is 7.78%.

Return on Equity (ROE)	15.04%
Return on Assets (ROA)	7.12%
Return on Invested Capital (ROIC)	7.78%
Return on Capital Employed (ROCE)	11.80%
Revenue Per Employee	96.45M
Profits Per Employee	30.92M
Employee Count	131
Asset Turnover	0.41
Inventory Turnover	1.23

Taxes

Income Tax	-761.26M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.73% in the last 52 weeks. The beta is -0.06, so PharmaEssentia's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	-27.73%
50-Day Moving Average	521.88
200-Day Moving Average	569.71
Relative Strength Index (RSI)	42.59
Average Volume (20 Days)	1,433,286

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of TWD 12.63 billion and earned 4.05 billion in profits. Earnings per share was 12.12.

Revenue	12.63B
Gross Profit	11.14B
Operating Income	3.48B
Pretax Income	3.29B
Net Income	4.05B
EBITDA	3.59B
EBIT	3.48B
Earnings Per Share (EPS)	12.12

Balance Sheet

The company has 20.78 billion in cash and 944.47 million in debt, giving a net cash position of 19.84 billion or 59.53 per share.

Cash & Cash Equivalents	20.78B
Total Debt	944.47M
Net Cash	19.84B
Net Cash Per Share	59.53
Equity (Book Value)	28.55B
Book Value Per Share	85.65
Working Capital	22.43B

Cash Flow

In the last 12 months, operating cash flow was 3.12 billion and capital expenditures -1.17 billion, giving a free cash flow of 1.95 billion.

Operating Cash Flow	3.12B
Capital Expenditures	-1.17B
Free Cash Flow	1.95B
FCF Per Share	5.86

Margins

Gross margin is 88.16%, with operating and profit margins of 27.52% and 32.06%.

Gross Margin	88.16%
Operating Margin	27.52%
Pretax Margin	26.04%
Profit Margin	32.06%
EBITDA Margin	28.45%
EBIT Margin	27.52%
FCF Margin	15.46%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.22%.

Dividend Per Share	1.10
Dividend Yield	0.22%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.68%
Shareholder Yield	-0.45%
Earnings Yield	2.45%
FCF Yield	1.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 30.12 and a Piotroski F-Score of 6.

Altman Z-Score	30.12
Piotroski F-Score	6